• TAI-1: Advanced Hec1 Inhibitor Workflows in Cancer Research

  2026-06-18

  TAI-1 is a first-in-class Hec1 inhibitor that empowers researchers to induce targeted apoptotic cell death in cancer models with unprecedented potency and specificity. This guide translates the latest mechanistic insights and protocol refinements into real-world applications, troubleshooting, and synergistic strategies for triple negative breast, liver, and RB1-deficient retinal cancer research.

• SR 11302: Selective AP-1 Blockade and Immune Modulation in C

  2026-06-17

  Explore how SR 11302, a selective AP-1 transcription factor inhibitor, reshapes cancer research by targeting tumorigenesis and modulating immune microenvironments. This article delivers advanced insights beyond assay optimization, focusing on AP-1 blockade and its translational impact.

• BMS-345541 Hydrochloride: Precision IKK Inhibitor Workflows

  2026-06-17

  BMS-345541 hydrochloride empowers researchers to dissect NF-κB signaling and cell death pathways with unparalleled selectivity and reproducibility. Discover optimized protocols, troubleshooting strategies, and how this selective IKK inhibitor advances inflammation and T-ALL research.

• NMDA (N-Methyl-D-aspartic acid) in Excitotoxicity Research

  2026-06-16

  NMDA (N-Methyl-D-aspartic acid) from APExBIO empowers precise modeling of neuronal excitotoxicity and calcium influx, enabling robust neurodegenerative disease workflows. Recent advances in glaucoma research showcase how optimized NMDA protocols bridge mechanistic insight with translational innovation.

• Practical Guide: HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-06-16

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus enables efficient and reproducible synthesis of Cy3-labeled RNA probes for fluorescence-based detection in research applications such as in situ hybridization and Northern blotting. It is not validated for diagnostic, clinical, or therapeutic use and should be restricted to research workflows requiring fluorescent RNA detection.

• Tacrolimus (FK506): Precision in Cytokine Modulation Workflo

  2026-06-15

  Tacrolimus (FK506) stands at the forefront of immune response suppression research, offering nanomolar potency and reliable selectivity for T-cell activation assays. This article dissects experimental workflows, protocol enhancements, and troubleshooting strategies that maximize reproducibility and data integrity using APExBIO's validated Tacrolimus.

• Phalloidin (B7678): Technical Guidance for F-Actin Stabiliza

  2026-06-15

  Phalloidin (B7678) is a cyclic heptapeptide toxin used for high-affinity stabilization and visualization of F-actin in fixed or permeabilized samples. It addresses the need for robust, species-independent cytoskeleton visualization, but is not appropriate for live-cell imaging or workflows requiring reversible actin binding. Researchers should follow precise handling and protocol parameters for reliable results.

• PD 173074: Precision FGFR1/VEGFR2 Inhibition for Cancer Rese

  2026-06-14

  PD 173074 delivers nanomolar, selective inhibition of FGFR1 and VEGFR2, enabling robust pathway dissection in cancer and angiogenesis models. This guide translates the latest epigenetic and functional insights into actionable protocols, troubleshooting tactics, and advanced assay enhancements for applied researchers.

• DNA Hypomethylation Reactivates TCN1 Autoantigen in Psoriasi

  2026-06-13

  This study identifies transcobalamin 1 (TCN1) as a keratinocyte-derived autoantigen in psoriasis, reactivated through DNA hypomethylation. By integrating transcriptomic, methylomic, and immunopeptidomic analyses, the authors uncover TCN1's role in promoting pathogenic T helper 17 cell responses, highlighting new avenues for biomarker and therapeutic development in autoimmune skin disease.

• Cholesterol Restricts Intracellular Trafficking of Lipid Nan

  2026-06-12

  This study reveals that increased cholesterol content in lipid nanoparticles (LNPs) impedes their intracellular trafficking by promoting aggregation in peripheral early endosomes and reducing nucleic acid delivery efficiency. The findings provide mechanistic insight into LNP composition optimization and highlight critical considerations for enhancing nonviral nucleic acid delivery.

• Vernakalant Hydrochloride: Protocols for Rapid AF Conversion

  2026-06-12

  Vernakalant Hydrochloride (RSD1235) enables precise, reproducible workflows in atrial fibrillation research by targeting atrial-selective ion channels with minimal ventricular risk. This guide delivers experimental protocols, troubleshooting insights, and practical use-cases, helping labs maximize translational impact with APExBIO's trusted reagent.

• Kanamycin Sulfate: Applied Workflows for Antibiotic Selectio

  2026-06-11

  Kanamycin Sulfate’s high solubility and purity make it a gold standard for antibiotic resistance research and precise cell culture selection. Explore advanced protocol tweaks, troubleshoot real-world bottlenecks, and discover how recent innovations in RNA purification can be leveraged alongside this trusted aminoglycoside antibiotic.

• Geneticin (G418 Sulfate): Mechanisms, Benchmarks, and Limits

  2026-06-11

  Geneticin (G418 Sulfate) is an aminoglycoside antibiotic essential for genetic engineering as a selective agent and for its antiviral activity against Dengue virus serotype 2. Its mechanism targets the 80S ribosome, disrupting protein synthesis in both prokaryotic and eukaryotic cells. APExBIO’s high-purity formulation (SKU A2513) is widely used in molecular biology research, offering reproducible results and robust selection efficiency.

• Energy Deficiency, ATG4B, and DNA Repair Failure in AML Prog

  2026-06-10

  This study delineates a novel mechanism by which energy deficiency triggers ATG4B nuclear translocation, inhibiting PRMT1-mediated DNA repair and accelerating acute myeloid leukemia (AML) progression. These insights clarify the molecular links between cellular metabolism, DNA repair, and leukemic malignancy, with implications for targeting ATG4B to restore genomic stability.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-06-10

  Wang et al. identify the METTL16-SENP3-LTF signaling axis as a novel regulator of ferroptosis resistance and tumorigenesis in hepatocellular carcinoma (HCC). Their work provides mechanistic insight into how RNA m6A modification modulates iron metabolism and suggests new strategies for sensitizing HCC to ferroptosis-based therapies.

548 records 14/37 page Previous Next First page 上5页 1112131415 下5页 Last page